Revenue
$48.48B
Gross Margin
+68.7%
Operating Margin
+25.7%
Net Margin
+15.0%
Income statement waterfall for Bristol-Myers Squibb (BMY) — TTM through Q1 2026
Net income: $7.28B
Margin breakdown for Bristol-Myers Squibb (BMY) — TTM through Q1 2026
| Line item | Amount | Running total |
|---|---|---|
| Revenue | $48.48B | $48.48B |
| Cost of Revenue | −$15.15B | $33.33B |
| Gross Profit | $33.33B | $33.33B |
| Operating Expenses | −$20.88B | $12.45B |
| Operating Income | $12.45B | $12.45B |
| Other Income / Expense | −$2.85B | $9.60B |
| Pre-tax Income | $9.60B | $9.60B |
| Income Tax | −$2.32B | $7.27B |
| Net Income | $7.28B | $7.28B |
- Revenue$48.48B
- Cost of Revenue−$15.15B
- Gross Profit$33.33B
- Operating Expenses−$20.88B
- Operating Income$12.45B
- Other Income / Expense−$2.85B
- Pre-tax Income$9.60B
- Income Tax−$2.32B
- Net Income$7.28B
Want to see what changed vs last year?Profit Bridge
Frequently asked questions
Data & methodology
Bristol-Myers Squibb (BMY) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement